Cargando…
COVID-19 and renal infarct: To be or not to be on anticoagulation
We present a unique case of a male veteran with a history of Castleman disease, presenting with multiple arterial and venous vascular thromboses in the setting of recent Coronavirus (COVID-19)-disease diagnosis. We explore this patient’s morbidity related to thrombotic complications of his COVID-19...
Autores principales: | Takamatsu, Chelsea, Devis, Paola, Tolouian, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594313/ https://www.ncbi.nlm.nih.gov/pubmed/34790516 http://dx.doi.org/10.5414/CNCS110602 |
Ejemplares similares
-
A novel oral anticoagulant, dabigatran, in acute renal infarction
por: Altın, Cihan, et al.
Publicado: (2015) -
Idiopathic Renal Infarction and Anticoagulation
por: Khayat, Maurice I., et al.
Publicado: (2019) -
Renal infarction associated with asymptomatic Covid-19 infection
por: Murray, Nigel P, et al.
Publicado: (2021) -
Splenic infarct in a COVID-19 patient under anticoagulant therapy with normal D-dimer levels
por: Atıcı, Semra Demirli, et al.
Publicado: (2022) -
Treat the patient not the lab value
por: Tolouian, Ramin, et al.
Publicado: (2010)